CN102078307A - 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 - Google Patents
一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102078307A CN102078307A CN2009102288991A CN200910228899A CN102078307A CN 102078307 A CN102078307 A CN 102078307A CN 2009102288991 A CN2009102288991 A CN 2009102288991A CN 200910228899 A CN200910228899 A CN 200910228899A CN 102078307 A CN102078307 A CN 102078307A
- Authority
- CN
- China
- Prior art keywords
- hydrochloric acid
- dronedarone
- acid dronedarone
- solid dispersion
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102288991A CN102078307B (zh) | 2009-12-01 | 2009-12-01 | 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102288991A CN102078307B (zh) | 2009-12-01 | 2009-12-01 | 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102078307A true CN102078307A (zh) | 2011-06-01 |
CN102078307B CN102078307B (zh) | 2012-11-07 |
Family
ID=44084634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102288991A Active CN102078307B (zh) | 2009-12-01 | 2009-12-01 | 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102078307B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2543361A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
EP2543363A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
EP2543362A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts |
WO2013004830A1 (fr) * | 2011-07-07 | 2013-01-10 | Sanofi | Composition pharmaceutique et forme galenique solide a haute teneur en dronedarone et son procede de preparation |
CN102908307A (zh) * | 2011-08-03 | 2013-02-06 | 天津市嵩锐医药科技有限公司 | 供注射用盐酸决奈达隆药物组合物及其制备方法 |
CN103054820A (zh) * | 2012-08-22 | 2013-04-24 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸决奈达隆药物组合物及其制备方法 |
CN103169691A (zh) * | 2011-12-22 | 2013-06-26 | 深圳信立泰药业股份有限公司 | 一种决奈达隆或其盐的粉末及由其制备的药物组合物 |
CN103565763A (zh) * | 2012-07-26 | 2014-02-12 | 山东新时代药业有限公司 | 一种盐酸决奈达隆片剂及其制备方法 |
WO2016120299A1 (en) * | 2015-01-28 | 2016-08-04 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Orally disintegrating formulations of dronedarone |
CN107184561A (zh) * | 2017-06-01 | 2017-09-22 | 四川制药制剂有限公司 | 盐酸决奈达隆片的生产工艺 |
CN108042500A (zh) * | 2017-12-19 | 2018-05-18 | 佛山市弘泰药物研发有限公司 | 一种盐酸决奈达隆口崩片及其制备方法 |
CN114557977A (zh) * | 2022-02-16 | 2022-05-31 | 北京康立生医药技术开发有限公司 | 一种治疗肠癌的药物的制备方法、制剂及纯度分析方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2764800B1 (fr) * | 1997-06-23 | 1999-09-10 | Sanofi Sa | Composition pharmaceutique solide contenant des derives de benzofuranne |
FR2875409B1 (fr) * | 2004-09-17 | 2010-05-07 | Sanofi Aventis | Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose |
CN100387229C (zh) * | 2004-12-06 | 2008-05-14 | 江永忠 | 盐酸胺碘酮分散片及其制备方法 |
CN100560067C (zh) * | 2006-09-29 | 2009-11-18 | 北京德众万全药物技术开发有限公司 | 盐酸决奈达隆口服药物组合物及其制备方法 |
-
2009
- 2009-12-01 CN CN2009102288991A patent/CN102078307B/zh active Active
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2543363A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
EP2543362A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts |
WO2013004830A1 (fr) * | 2011-07-07 | 2013-01-10 | Sanofi | Composition pharmaceutique et forme galenique solide a haute teneur en dronedarone et son procede de preparation |
FR2977495A1 (fr) * | 2011-07-07 | 2013-01-11 | Sanofi Sa | Composition pharmaceutique et forme galenique solide a haute teneur en dronedarone et son procede de preparation |
EP2543361A1 (en) * | 2011-07-07 | 2013-01-09 | Sanofi | Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts |
CN102908307A (zh) * | 2011-08-03 | 2013-02-06 | 天津市嵩锐医药科技有限公司 | 供注射用盐酸决奈达隆药物组合物及其制备方法 |
CN103169691B (zh) * | 2011-12-22 | 2016-08-17 | 深圳信立泰药业股份有限公司 | 一种决奈达隆或其盐的粉末及由其制备的药物组合物 |
CN103169691A (zh) * | 2011-12-22 | 2013-06-26 | 深圳信立泰药业股份有限公司 | 一种决奈达隆或其盐的粉末及由其制备的药物组合物 |
CN103565763A (zh) * | 2012-07-26 | 2014-02-12 | 山东新时代药业有限公司 | 一种盐酸决奈达隆片剂及其制备方法 |
CN103565763B (zh) * | 2012-07-26 | 2016-09-07 | 山东新时代药业有限公司 | 一种盐酸决奈达隆片剂及其制备方法 |
CN103054820A (zh) * | 2012-08-22 | 2013-04-24 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸决奈达隆药物组合物及其制备方法 |
WO2016120299A1 (en) * | 2015-01-28 | 2016-08-04 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Orally disintegrating formulations of dronedarone |
CN107184561A (zh) * | 2017-06-01 | 2017-09-22 | 四川制药制剂有限公司 | 盐酸决奈达隆片的生产工艺 |
CN108042500A (zh) * | 2017-12-19 | 2018-05-18 | 佛山市弘泰药物研发有限公司 | 一种盐酸决奈达隆口崩片及其制备方法 |
CN114557977A (zh) * | 2022-02-16 | 2022-05-31 | 北京康立生医药技术开发有限公司 | 一种治疗肠癌的药物的制备方法、制剂及纯度分析方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102078307B (zh) | 2012-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078307B (zh) | 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 | |
CN100560067C (zh) | 盐酸决奈达隆口服药物组合物及其制备方法 | |
EP2167046B1 (en) | Pharmaceutical solid preparation comprising benzazepines and production method thereof | |
EP2586464B1 (en) | Tolvaptan solid dispersion and its preparation method | |
KR20100012867A (ko) | 타다라필을 포함하는 고체 제형 | |
CN102481281B (zh) | 决奈达隆固体分散体及其制备方法 | |
CN101516338A (zh) | 一种含有非诺贝特的口服药物组合物及其制备方法 | |
CN101816637B (zh) | 来氟米特片制剂及其制备方法 | |
CN102908305B (zh) | 一种含有盐酸决奈达隆的口服固体药物组合物及其制备方法 | |
CN102406622B (zh) | 一种托伐普坦的固体制剂 | |
CN102600132A (zh) | 一种含氨磺必利的口服制剂 | |
CN105496966A (zh) | 一种恩格列净固体分散体的药物组合物及其制备方法 | |
CN101947219B (zh) | 一种复方替米沙坦苯磺酸氨氯地平药物组合物及其制备方法 | |
CN104069068A (zh) | 炔丙基半胱氨酸固体分散体及其制备方法和用途 | |
CN105412027A (zh) | 一种盐酸决奈达隆片剂的制备方法 | |
CN101836981B (zh) | 复方缬沙坦苯磺酸氨氯地平药物组合物及其制备方法 | |
CN103054820A (zh) | 一种盐酸决奈达隆药物组合物及其制备方法 | |
CN107868009B (zh) | 一种酒石酸美托洛尔晶体及含该晶体的药物组合物及其制备方法 | |
CN102068415B (zh) | 一种咔唑磺酰胺类抗肿瘤药物分散片及其制备方法 | |
KR102228135B1 (ko) | 레스베라트롤을 포함하는 고형 제제 형태의 약학 조성물 및 레스베라트롤의 가용화 방법 | |
KR100539706B1 (ko) | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 | |
CN101721414B (zh) | 含有盐酸吡格列酮和盐酸二甲双胍的组合物及其制备 | |
CN101491523A (zh) | 含微粉化格列喹酮的组合物 | |
CN109985015A (zh) | 一种高效降糖的格列美脲片 | |
CN104138363A (zh) | 一种硝苯地平缓释片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN HANKANG PHARMACEUTICAL BIOTECHNOLOGY CO., Free format text: FORMER OWNER: YAN JIE Effective date: 20120210 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120210 Address after: 300203, Tianjin Dagu South Road, respect 4, 3, Hexi District Applicant after: Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. Address before: 300203, Tianjin Dagu South Road, respect 4, 3, Hexi District Applicant before: Yan Jie |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190211 Address after: 475000 Minfa Road, Jinming Industrial Park, Kaifeng City, Henan Province Patentee after: Kaifeng song Pharmaceutical Co., Ltd. Address before: 300203 Tianjin Hexi District Dagu South Road 4, 3 Patentee before: Tianjin Hankang Pharmaceutical Biotechnology Co., Ltd. |